While accounting for a smaller fraction of CRISPR publications (Figure ), nervous system disorders still contribute about 7% and 6% of journal articles and patents in the field of CRISPR. Supplementary Figure further shows the breakdown of publication trend across various nervous system disorders -a key takeaway is that the rate of growth of publications in the field of CRISPR co-occurring with Alzheimer's and Parkinson's diseases has increased over the last decade indicating interest from both academic researchers as well as commercial entities. CRISPR/Cas9 technology has gained popularity in the field of neurodegenerative diseases due to its short experimental duration and easy molecular engineering requirements. It is currently being extensively utilized for building disease models, identifying pathogenic genes through screening, and for targeted therapy.